| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1628732-62-6 | Olinciguat | C21H16F5N7O3 |
| 1628749-20-1 | Tri-O-triglycidylresveratrol | C23H24O6 |
| 1628752-98-6 | 10-(4-(4,6-Diphenyl-1,3,5-triazin-2-yl)phenyl)-9,9-dimethyl-9,10-dihydroacridine | C36H28N4 |
| 1628790-37-3 | Cy5.5 alkyne | C43H46ClN3O |
| 1628806-43-8 | (4R)-4-[(1S)-1-Fluoroethyl]-3-(2-fluoro-4-pyrimidinyl)-2-oxazolidinone | C9H9F2N3O2 |
| 1628838-42-5 | N-[2-Methyl-5'-(4-morpholinyl)-6'-[(tetrahydro-2H-pyran-4-yl)oxy][3,3'-bipyridin]-5-yl]-3-(trifluoromethyl)benzamide | C28H29F3N4O4 |
| 1629229-37-3 | Fezolinetant | C16H15FN6OS |
| 1629249-40-6 | Integrin Antagonist 1 hydrochloride | C29H38ClN5O2 |
| 1629265-17-3 | K-Ras G12C-IN-1 | C22H23Cl2N3O3 |
| 1629267-75-9 | K-Ras G12C-IN-2 | C21H27ClN4O3 |
| 1629268-00-3 | 1-[3-[4-[2-[[4-Chloro-2-hydroxy-5-(1-methylcyclopropyl)phenyl]amino]acetyl]-1-piperazinyl]-1-azetidinyl]-2-propen-1-one | C22H29ClN4O3 |
| 1629268-19-4 | K-Ras G12C-IN-3 | C21H19Cl3N2O3 |
| 1629579-82-3 | 3,3'-[Oxybis(2,1-ethanediyloxy)]bis-1-propanamine (2Z)-2-butenedioate (1:2) | C10H24N2O3.2(C4H4O4) |
| 1629618-98-9 | Trenbolone Enanthate | C25H34O3 |
| 1629896-95-2 | (4S)-2-(5,7-difluoro-6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid | C11H6F2N2O3S2 |
| 1630193-77-9 | 2,5-Dimethoxypyridine-4-boronic acid | C7H10BNO4 |
| 1630724-71-8 | 1,3-Di-O-galloyl-4,6-hexahydroxydiphenoyl-beta-4C1-glucopyranose | C34H26O22 |
| 1630761-22-6 | Levosimendan impurity 01 | C11H11BF4N4O |
| 1630815-44-9 | (3S,4R)-4-aminooxan-3-ol hydrochloride | C5H12ClNO2 |
| 1630815-57-4 | N-[(3R,4S)-3-Fluoro-4-piperidinyl]carbamic acid 1,1-dimethylethyl ester | C10H19FN2O2 |
| 1630906-40-9 | trans-4-(5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol | C12H13BrClN3O |
| 1630906-49-8 | N-[(3-Aminobicyclo[1.1.1]pent-1-yl)methyl]carbamic acid 1,1-dimethylethyl ester | C11H20N2O2 |
| 1630906-60-3 | 2,5-Diazaspiro[3.4]octane-5-carboxylic acid 1,1-dimethylethyl ester ethanedioate (2:1) | 2(C11H20N2O2).C2H2O4 |
| 1630970-05-6 | Albatrelin G | C22H32O3 |
| 1631053-75-2 | Tirofiban impurity 04 | C23H38N2O5S |
| 1631754-41-0 | Biafungin acetate | C65H88N8O19 |
| 1632032-53-1 / 1026680-07-8 | rel-(1R,4S)-3-[(4-Methyl-1-piperazinyl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid | C13H20N2O4 |
| 1632047-58-5 | 3-(1,4-Dioxaspiro[4.5]dec-7-en-8-yl)benzenemethanol | C15H18O3 |
| 1632110-81-6 | (2S)-2-[1-(beta-D-Glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-7-(hydroxymethyl)-4-methoxy-5H-furo[3,2-g][1]benzopyran-5-one | C22H28O11 |
| 1632118-69-4 | (3alpha,5beta,6beta,7beta)-6-Ethylcholane-3,7,24-triol | C26H46O3 |
| 1632118-70-7 | (3alpha,5beta,6beta,7alpha)-6-Ethylcholane-3,7,24-triol | C26H46O3 |
| 1632287-34-3 | Dapagliflozin MonoAcetyl Impurity | C23H27ClO7 |
| 1632312-32-3 | 4-Methylphenyl 6-deoxy-2-O-(phenylmethyl)-1-thio-beta-L-galactopyranoside 3,4-diacetate | C24H28O6S |
| 1632315-11-7 | CPI 200K | C24H19S2.C6H15F3P |
| 1632463-24-1 | 5-Chloro-N-[4-[(5S)-5-[[[(5-chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]-N-[2-[2-oxo-2-[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]ethoxy]ethyl]-2-thiophenecarboxamide | C38H36Cl2N6O10S2 |
| 1632485-14-3 | 2,5-Dichloro-N-[2-[(1-methylethyl)thio]phenyl]-4-pyrimidinamine | C13H13Cl2N3S |
| 1633044-56-0 | N-[4-[[3-(3,5-Dimethoxyphenyl)-3,4-dihydro-7-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-2-oxopyrimido[4,5-d]pyrimidin-1(2H)-yl]methyl]phenyl]-2-propenamide | C35H38N8O4 |
| 1636114-55-0 | (3beta,12beta,20Z)-12,25-Dihydroxydammar-20(22)-en-3-yl beta-D-glucopyranoside | C36H62O8 |
| 1636130-32-9 | 1-(3-Bromo-5-(tert-butyl)phenyl)-1H-imidazole | C13H15BrN2 |
| 1637254-93-3 | (2E)-4-Bromo-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide | C22H19BrClFN4O3 |
| 1637297-21-2 | 59-Azido-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-nonadecaoxanonapentacontan-1-ol | C40H81N3O20 |
| 1637413-81-0 | [(6-{[(2R,3R,4R,5R,6R)-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-acetamidooxepan-2-yl]oxy}hexyl)carbamoyl]ethoxy)methyl]propan-2-yl)carbamoyl]butanoate | C88H137N7O36 |
| 1637443-98-1 | hVEGF-IN-1 | C34H43N7O2 |
| 1637542-33-6 | (alphaS)-alpha-[2-Chloro-4-fluoro-5-[7-(4-morpholinyl)-4-quinazolinyl]phenyl]-6-methoxy-3-pyridazinemethanol | C24H21ClFN5O3 |
| 1637660-36-6 | 5,9-Dibromo-7H-benzo[c]fluoren-7-one | C17H8Br2O |
| 1637739-82-2 | 6-Amino-1,4-dihydro-1,3-dimethyl-4-[4-(trifluoromethyl)phenyl]pyrano[2,3-c]pyrazole-5-carbonitrile | C16H13F3N4O |
| 1637752-63-6 | 5-Phenyl-5,8-dihydroindolo[2,3-c]carbazole | C24H16N2 |
| 1637781-10-2 | 2-Amino-6-bromo-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | C13H15BrN4O |
| 1638178-82-1 | 2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one hydrochloride (1:2) | C24H26N4O .2ClH |
| 1638178-87-6 | Onc-206 | C23H22F2N4O |